The University of Minnesota Medical School is the medical school of the University of Minnesota. It is a combination of two campuses situated in Minneapolis and Duluth, Minnesota. The University of Minnesota Medical School is also part of one of the largest Academic Health Centers in the United States.

During the past decade, University of Minnesota Medical School conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Minnesota Medical School" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "National Institute of Mental Health (NIMH)" with 4 trials sponsored, "Biogen" with 2 trials sponsored, "University of Chicago" with 2 trials sponsored and "University of Minnesota" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota Medical School" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "University of Minnesota" with 2 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Minnesota Medical School" are "Schizophrenia" (4 trials), "Gambling" (2 trials), "HIV Infections" (2 trials), "Tobacco Use Disorder" (2 trials) and "Acid Maltase Deficiency" (1 trials). Many other conditions were trialed in "University of Minnesota Medical School" in a lesser frequency.

Most popular intervention types in "University of Minnesota Medical School" are "Drug" (28 trials), "Other" (6 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BIIB092" (2 trials), "Lamivudine" (2 trials), "Metformin" (2 trials) and "Zidovudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Minnesota Medical School" are 37 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Minnesota Medical School". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in University of Minnesota Medical School, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Minnesota Medical School, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".